Veriti Management LLC Supernus Pharmaceuticals, Inc. Transaction History

Veriti Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 26, 2022	SELL	$28.79 - $35.41 $13,358 - $16,430	-464 Reduced 4.8%	9,209 $312,000
Q2 2022 Jul 18, 2022	BUY	$25.33 - $34.25 $19,504 - $26,372	770 Added 8.65%	9,673 $280,000
Q1 2022 Apr 11, 2022	BUY	$28.51 - $32.9 $20,527 - $23,688	720 Added 8.8%	8,903 $288,000
Q3 2021 Oct 08, 2021	BUY	$23.54 - $31.39 $192,627 - $256,864	8,183 New	8,183 $218,000
Q1 2021 Apr 14, 2021	SELL	$24.15 - $31.45 $163,785 - $213,293	-6,782 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$17.7 - $25.81 $120,041 - $175,043	6,782 New	6,782 $171,000

282

60.9M

27.7K

11.3K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.94B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Veriti Management LLC, based on Form 13F filings with the SEC.

Stay updated on Veriti Management LLC with notifications on news.